NCT06332534 Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE3
NCT06299631 Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease Status COMPLETED Phase N/A
NCT06274554 Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease Status RECRUITING Phase PHASE3
NCT06249555 VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06244849 TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study Status NOT_YET_RECRUITING Phase NA
NCT06233461 A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE2
NCT06227910 A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease Status RECRUITING Phase PHASE3
NCT06226883 A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE2
NCT06180382 Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. Status RECRUITING Phase PHASE4
NCT06126146 An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK) Status COMPLETED Phase N/A
NCT06100289 A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Status RECRUITING Phase PHASE3
NCT06064864 Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD Status RECRUITING Phase NA
NCT06063967 A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06053424 Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease Status COMPLETED Phase PHASE1
NCT06045754 A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease Status RECRUITING Phase PHASE4
NCT06031038 Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU Status COMPLETED Phase NA
NCT06023030 An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan Status RECRUITING Phase N/A